Remove 2018 Remove Economics Remove Public Trading
article thumbnail

Private Equity’s Increasing Consolidation of Oncology Practices 

Focus Investment Banking

The company itself was formed in 2018 by another PE firm, General Atlantic, which is selling out of its position in the new deal. A big part of oncology is buying and billing chemotherapy, and we're able to improve their economics there substantially with national buying power,” Patton told OBR. Alliance Health Services.

article thumbnail

Public SaaS Company Valuations and What They Mean for Private Companies

Software Equity Group

Stock prices and valuations of many leading public SaaS companies have fallen drastically from the beginning of 2022—but while that will affect the private market, it does not necessarily spell doom and gloom. This post will examine the current state of public SaaS company valuations and what it means for private companies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Funding M&A Deals with Bitcoin

Deal Law Wire

In 2018, prior to the impact of the global pandemic, there were 189 M&A deals involving cryptocurrency companies within the 25 most active cryptocurrency jurisdictions, worth approximately US$1.9 As of February 11, 2021, the OSC gave the green light for the first publicly traded bitcoin exchange-traded funds in North America.

M&A 40
article thumbnail

Transfer Traps: Considerations for Dual-Class Companies Contemplating M&A Transactions

Cooley M&A

In addition, currently public dual-class companies with transfer provisions that do not contain clear carve outs for the delivery of voting agreements in the M&A context should discuss with their advisers the possibility of adopting “clear day” amendments to their charters to include these carve outs. Vote-down termination fee (i.e.,

M&A 59
article thumbnail

Momentum Builds for Ophthalmology Recapitalizations

Focus Investment Banking

McKesson, a public company with approximately $76 billion in market value, will purchase an 80% interest in PRISM for approximately $850M. PRISM was founded in 2018 with Quad-C Managements acquisition of NJ Retina, a large Retina practice in New Jersey.